i3 Health Presents Oncology Nursing Showdown: Non-Hodgkin Lymphoma Edition at Oncology Nursing Society Congress

i3 Health's study focusing on the effectiveness of a nursing continuing professional development (NCPD)–approved activity to improve clinicians' knowledge of the individualized treatment of patients with non-Hodgkin lymphoma (NHL) has been published as a 47th Annual Oncology Nursing Society (ONS) Congress online abstract. The abstract, authored by Elizabeth Heller, PhD; Keira Smith, BA; Kristin Wright, PharmD; and Sarah Williams, MAT, of i3 Health, and Maria Badillo, MSN, RN, OCN®, CCRP, Researc...

Continue reading

Exploring Symptom Science Interventions With Nada Lukkahatai, PhD, MSN, RN, FAAN

 At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Nada Lukkahatai of Johns Hopkins School of Nursing gave a presentation about symptom science and her research regarding nonpharmacological interventions to reduce symptom burden. In this interview with Oncology Data Advisor, Dr. Lukkahatai further delves into this research and explains the future of personalized interventions and biomarkers studies for symptom management.

Continue reading

Enhancing Nurse Well-Being by Building Resiliency to Trauma With Bina Parekh, PhD

At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Bina Parekh, PhD, explained the concept of vicarious trauma and empowered nurses with positive personal growth strategies to deal with challenges, fears, and trauma that stem from dealing with patients with cancer. In this interview with Oncology Data Advisor, Dr. Parekh discusses the concept of vicarious trauma and how nurses, programmed to care for others, are often affected. She shares advice for nurses on how to ad...

Continue reading

Considering CAR T-Cell Therapy Survivorship Care With Sherry Adkins, ANP-C

At the recent 47th Oncology Nursing Society (ONS) Congress in Anaheim, California, Sherry Adkins, MSN, ANP-C, Advanced Practice Provider Supervisor at MD Anderson Cancer Center, gave a presentation entitled CAR T-Cell Therapy: Care and Considerations Beyond Day 28. She highlighted the fact that although the most common acute toxicities associated with chimeric antigen receptor (CAR) T-cell therapy, including cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndro...

Continue reading

Starting the Conversation About the Cost of Cancer Care With Mateo Banegas, PhD, MPH

At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Mateo Banegas of the University of California, San Diego (UCSD) gave a presentation about the financial toxicity of cancer care, particularly during the COVID-19 pandemic. In this interview with Oncology Data Advisor, Dr. Banegas shares additional advice for members of the cancer care team on how to engage in conversations about financial costs and well-being with their patients.  

Continue reading

Exploring Cognitive Function Research for Cancer Survivorship With Diane Von Ah, PhD, RN, FAAN

At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Diane Von Ah, Distinguished Professor of Cancer Research at The Ohio State University College of Nursing, gave a presentation about the current state of research regarding cognitive impairment and functional limitation among cancer patients and survivors. In this interview, Dr. Von Ah further expands on her research in this field and explains the role of nurses in improving patients' quality of life both during and after treatment.  

Continue reading

Providing Optimal Care for Cancer Patients in Rural Alaska With Joscelyn VanDuren, MSN, FNP-C

At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Joscelyn VanDuren, Family Nurse Practitioner at Advanced Oncology Associates in Alaska, gave a presentation about the challenges faced by patients receiving cancer treatment in rural Alaska and her experiences in treating them. Afterwards, she spoke with Oncology Data Advisor to share additional strategies for nurses and nurse practitioners for providing optimal care for their patients residing in rural areas.  

Continue reading

Survey of Oncology Nurses Reveals Need for Knowledge Regarding Genetic Evaluation and LGBTQIA+ Cancer Care

In May of 2022, i3 Health conducted a survey of 230 oncology nurses at the Oncology Nursing Society (ONS) 47th Annual Congress in Anaheim, California, to assess nurses' familiarity and desire to understand genetic evaluation and counseling and LGBTQIA+ cancer care. Genetic evaluation and counseling are ways for patients to better understand their genome and how their DNA might be able to warn them, and even their family, about their risks to certain cancers and diseases. There are a variety of t...

Continue reading

Reigniting the Passion as an Oncology Nurse With Nicola Stewart, MHL, BSN, RN-BC, OCN®

At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Nicola Stewart, Oncology Nurse Navigator at Methodist Healthcare/Sarah Cannon Cancer Institute, gave a presentation about boosting nursing morale by investing in the individual person and building the team. In this interview with Oncology Data Advisor, she shares additional advice for reigniting the passion as an oncology nurse, including the importance of remembering your "why."  

Continue reading

Raising Awareness About Medical Aid in Dying With Janet Rowe and Lisa Vigil Schattinger

At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Janet Rowe, RN, and Lisa Vigil Schattinger, MSN, RN, gave a presentation about medical aid in dying and the nurse's role in supporting their terminally ill patients' rights to autonomous decision-making. In this interview with Oncology Data Advisor, Ms. Rowe and Ms. Vigil Schattinger discuss their own experiences with medical aid in dying, explain their work to spread awareness and provide education to the community, and share additional advice for nurses on how to engage patients and families in meaningful conversations about this important issue.

Continue reading

Supporting Patients Who Are Experiencing Financial Toxicity With Grace Smith, MD, PhD, MPH

At the recent Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Grace Smith, Associate Professor at MD Anderson Cancer Center, gave a presentation about the financial toxicity associated with cancer care, particularly in light of the COVID-19 pandemic. In this interview with Oncology Data Advisor, Dr. Smith shares advice for nurses about how they can help prepare, identify, evaluate, and support patients who may experience financial toxicity.  

Continue reading

Designing Innovative Education for Nursing Development With Leah Scaramuzzo and Alisha Ellis

At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Leah Scaramuzzo, MSN, RN, MEDSURG-BC, AOCN®, Nursing Director for Oncology Clinical Development at Logan Health, and Alisha Ellis, MSN, RN, OCN®, CHPN, BMTCN®, Staff Nurse and Educator in the Bone Marrow Transplant and Hematology Unit at Franciscan Health, presented an engaging session on how to Capture Your Audience With Innovative Education. Afterwards, they spoke with Oncology Data Advisor to continue their conversation and provide further expertise on how implement creative educational resources into practice, for both patients and providers.  

Continue reading

From the Patient’s Perspective: Improving Quality of Care for the LGBTQIA+ Community With Reverend Sean Parker Dennison

Oncology Data Advisor™ · From the Patient’s Perspective: Improving Quality of Care for the LGBTQIA+ Community At the recent 47th Annual Oncology Nursing Society (ONS) Congress, Reverend Sean Parker Dennison, alongside three other professionals, held a panel that explored the topic of improving quality of care for LGBTQIA+ individuals with cancer. In this follow-up interview with Oncology Data Advisor, Reverend Sean expands on their thoughts and provides the valuable perspectiv...

Continue reading

Behind All Great Cancer Care Is a Great Oncology Nurse: Jeannine Brant, PhD, APRN, AOCN®, FAAN

Oncology Data Advisor™ · The Nurse's Role in Oncology Research and Quality Care: Jeannine Brant, PhD, APRN At the recent American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Jeannine Brant, PhD, APRN, President of the Oncology Nursing Society (ONS), sat down with Oncology Data Advisor to talk about the exciting research being presented by nurses at ASCO and the critical role of nurses in delivering quality oncology care. This podcast episode was recorded live at t...

Continue reading

A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD: May 2022

From my perch atop the masthead at Oncology Data Advisor, I am awed by the dozens of oncology professionals who give freely of their time and expertise to inform our readership of the latest in their respective areas. Their efforts are what make ODA a premier online resource for all things in this ever-evolving field. My heartfelt thanks go to these wonderful colleagues without whom we would cease to be a publication. In this month's Editor's Letter, I would like to highlight a few of the outsta...

Continue reading

Survey of Oncology Nurses Reveals Knowledge Gaps Surrounding Biosimilars

A biosimilar is a biological agent that is very much like another previously FDA-approved biological agent, called the reference drug. Biosimilars and their reference drugs are both made from living organisms, but they may be made in different ways and of slightly different substances. A biosimilar must demonstrate the same safety and efficacy and work in the same way as the reference drug, and it must also be used in the same way, at the same dose, and for the same condition. There are currentl...

Continue reading

Survey of Oncology Nurses Reveals Knowledge Gaps Surrounding Immune Checkpoint Inhibitors

Immune checkpoint inhibition is a form of immunotherapy that blocks checkpoint proteins on immune cells, boosting the body's immune response against cancer cells. Checkpoint inhibitors such as pembrolizumab (Keytruda®, Merck), nivolumab (Opdivo®, Bristol-Myers Squibb), atezolizumab (Tecentriq®, Genentech), durvalumab (Imfinzi®, AstraZeneca), cemiplimab (Libtayo®, Regeneron Pharmaceuticals, Inc.), ipilimumab (Yervoy®, Bristol-Myers Squibb), and avelumab (Bavencio®, EMD Serono and Pfizer) have dem...

Continue reading

Surveys Reveal Oncology Nurses’ CNE Preferences

​At the Oncology Nursing Society (ONS) 44th Annual Congress in Anaheim, California, in April 2019, i3 Health surveyed oncology nurses regarding their educational needs on a variety of topics, including immune checkpoint inhibitors, cyclin dependent kinase (CDK)4/6 inhibitors, chimeric antigen receptor (CAR) T-cell therapy, poly(ADP)-ribose polymerase (PARP) inhibitors, and biosimilars. Regardless of the survey topic, all respondents were asked about their practice role, practice setting, and pre...

Continue reading

Preparing Nurses to Manage CAR T-Cell Therapy Adverse Events With Lindsey Bashaw, RN

Chimeric antigen receptor (CAR) T-cell therapy is a new form of immunotherapy in which a patient's own T cells are collected and genetically altered to target cancer cells. Although CAR T-cell therapy has shown encouraging clinical trial results in patients with acute lymphoblastic leukemia and B-cell lymphomas, they are associated with severe adverse events such as cytokine release syndrome, neurotoxicity, tumor lysis syndrome, and graft-versus-host disease. Many of the patients who receive CAR...

Continue reading

Exploring the Effects of Chemo Brain in Breast Cancer Patients With Patricia A. Gibbons, PhD, RN, AOCN

Many patients with cancer who receive systemic therapy experience cancer treatment-related cognitive impairment, commonly referred to as "chemo brain." Chemo brain is characterized by the inability to remember certain things and having trouble finishing tasks or learning new skills. For most patients, these effects are short-term; however, other patients may have long-term mental changes which negatively impact their everyday life. At the Oncology Nursing Society 43rd Annual Congress in Washingt...

Continue reading

Copyright © 2022 Oncology Data Advisor. All rights reserved.